1[1]Chaturvedi S,Yadav JS.The role of antiplatelet therapy in carotid stenting for ischemic stroke prevention[J].Stroke,2006,37:1572-1577.
2[2]Wenaweser P,D(o)rffler-Melly J,Imboden K,et al.Stent thrombosis is associated with an impaired response to antiplatelet therapy[J].J Am Coll Cardiol,2005,45:1748-1752.
3[3]Lev EI,Patel RT,Maresh KJ,et al.Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistance[J].J Am Coll Cardiol,2006,47:27-33.
4[4]Müller I,Besta F,Schulz C,et al.Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement[J].Thromb Haemost,2003,89:783-787.
5[5]North American Symptomatic Carotid Endarterectomy Trial Collaborators.Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis[J].N Engl J Med,1991,325:445-453.
6[6]Cattaneo M.Resistance to antiplatelet drugs:molecular mechanisms and laboratory detection[J].J Thromb Haemost,2007,5 (Suppl 1):230-237.
7[7]Nguyen TA,Diodati JG,Pharand C.Resistance to clopidogrel:a review of the evidence[J].J Am Coll Cardiol,2005,45:1157-1164.
8[8]Müller I,Seyfarth M,Rudiger S,et al.Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement[J].Heart,2001,85:92-93.
9[9]Weerakkody GJ,Brandt JT,Payne CD,et al.Clopidogrel poor responders:an objective definition based on Bayesian classification[J].Platelets,2007,18:428-435.
10[10]Dropinski J,Jakiela B,Sanak M,et al.The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin[J].Thromb Haemost,2007,98:201-209.
7Collaborativemeta-analysis of randomized trials ofantiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [ J ]. BMJ, 2002,324 : 71- 86.
8Antithrombotic Trialists Collaboration. Collaborative meta analysis of random is edtrial of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [ J ]. Br Med J ,2002,324 (7329) :71-86.
9Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol,2001,88 :230-235.
10Lev El, Patel RT, Maresh KJ, et al. Aspirin and clopigrel drug response in patients undergoing percutaneous coronary intervention : the role of dual drug resistance [ J ]. J Am Coil Cardiol,2006,47( 1 ) :27-33.
